<DOC>
	<DOCNO>NCT01336218</DOCNO>
	<brief_summary>The purpose study investigate drug interaction fostamatinib rifampicin compare safety , tolerability plasma concentration fostamatinib administer alone rifampicin healthy subject</brief_summary>
	<brief_title>Effects Administration Fostamatinib Blood Concentrations Rifampicin Healthy Subjects .</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<criteria>Provision inform consent prior study specific procedure Males female age 18 55 year ( inclusive ) Minimum weight 50 kg body mass index ( BMI ) 18 35 kg/m2 ( inclusive ) Female subject must negative pregnancy test screen admission treatment period , must lactate , must nonchildbearing potential History presence gastrointestinal , hepatic renal disease ( except cholecystectomy ) Any clinically significant illness , medical surgical procedure , trauma within 4 week Period 1 Day 1 Subjects smoke 5 cigarette equivalent tobacco per day Absolute neutrophil count less 2500/mm3 2.5 x 109/L Any previous treatment fostamatinib</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>RA</keyword>
	<keyword>Fostamatinib</keyword>
	<keyword>Rifampicin</keyword>
	<keyword>drug-drug interaction</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Amount Rifampicin blood</keyword>
</DOC>